Lip GYH - Search Results

1

Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation.

Esteve-Pastor MA, Rivera-Caravaca JM, Roldán V, Orenes-Piñero E, Romiti GF, Romanazzi I, Bai Y, Carmo J, Proietti M, Marín F, Lip GYH. Esteve-Pastor MA, et al. Among authors: lip gyh. Am J Cardiol. 2018 Sep 1;122(5):785-792. doi: 10.1016/j.amjcard.2018.05.012. Epub 2018 Jun 2. Am J Cardiol. 2018. PMID: 30049460

2

A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.

Kamath S, Blann AD, Chin BS, Lip GY. Kamath S, et al. J Am Coll Cardiol. 2002 Aug 7;40(3):484-90. doi: 10.1016/s0735-1097(02)01984-8. J Am Coll Cardiol. 2002. PMID: 12142115 Free article. Clinical Trial.

3

Do protein Z levels influence the prothrombotic state in atrial fibrillation?

Marco P, Marín F, García A, Roldán V, Lip GY. Marco P, et al. Thromb Res. 2002 May 15;106(4-5):269-70. doi: 10.1016/s0049-3848(02)00142-1. Thromb Res. 2002. PMID: 12297137 No abstract available.

4

Atrial fibrillation in the elderly: anticoagulation strategies and indications in the very elderly.

Kamath S, Lip GY. Kamath S, et al. Am J Geriatr Cardiol. 2002 Nov-Dec;11(6):357-62; quiz 363-4. doi: 10.1111/j.1076-7460.2002.00070.x. Am J Geriatr Cardiol. 2002. PMID: 12417841 Review.

5

Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?

Marín F, Roldán V, Climent V, Garcia A, Marco P, Lip GY. Marín F, et al. Stroke. 2003 May;34(5):1181-6. doi: 10.1161/01.STR.0000065431.76788.D9. Epub 2003 Mar 27. Stroke. 2003. PMID: 12663879

6

Fibrinolytic function and atrial fibrillation.

Marín F, Roldán V, Lip GY. Marín F, et al. Thromb Res. 2003 Mar 15;109(5-6):233-40. doi: 10.1016/s0049-3848(03)00259-7. Thromb Res. 2003. PMID: 12818244 Review.

7

Fibrin D-dimer levels in atrial fibrillation as an index of thrombogenesis: a possible test to exclude left atrial thrombus?

Tayebjee MH, Lip GY. Tayebjee MH, et al. Am J Cardiol. 2003 Jul 1;92(1):47-9. doi: 10.1016/s0002-9149(03)00463-6. Am J Cardiol. 2003. PMID: 12842244 No abstract available.

8

Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation.

Roldán V, Marín F, Blann AD, García A, Marco P, Sogorb F, Lip GY. Roldán V, et al. Eur Heart J. 2003 Jul;24(14):1373-80. doi: 10.1016/s0195-668x(03)00239-2. Eur Heart J. 2003. PMID: 12871695

9

Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature.

Roldán V, Marín F, Lip GY, Blann AD. Roldán V, et al. Thromb Haemost. 2003 Dec;90(6):1007-20. doi: 10.1160/TH02-09-0083. Thromb Haemost. 2003. PMID: 14652631 Review.

10

Ethnicity in relation to atrial fibrillation and stroke (the West Birmingham Stroke Project).

Conway DS, Lip GY. Conway DS, et al. Am J Cardiol. 2003 Dec 15;92(12):1476-9. doi: 10.1016/j.amjcard.2003.08.065. Am J Cardiol. 2003. PMID: 14675592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,454 results

Search Page